Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 24;12(1):32.
doi: 10.1186/1532-429X-12-32.

Quantification of left ventricular remodeling in response to isolated aortic or mitral regurgitation

Affiliations

Quantification of left ventricular remodeling in response to isolated aortic or mitral regurgitation

Seth Uretsky et al. J Cardiovasc Magn Reson. .

Abstract

Background: The treatment of patients with aortic regurgitation (AR) or mitral regurgitation (MR) relies on the accurate assessment of the severity of the regurgitation as well as its effect on left ventricular (LV) size and function. Cardiovascular Magnetic Resonance (CMR) is an excellent tool for quantifying regurgitant volumes as well as LV size and function. The 2008 AHA/ACC management guidelines for the therapy of patients with AR or MR only describe LV size in terms of linear dimensions (i.e. end-diastolic and end-systolic dimension). LV volumes that correspond to these linear dimensions have not been published in the peer-reviewed literature. The purpose of this study is to determine the effect of regurgitant volume on LV volumes and chamber dimensions in patients with isolated AR or MR and preserved LV function.

Methods: Regurgitant volume, LV volume, mass, linear dimensions, and ejection fraction, were determined in 34 consecutive patients with isolated AR and 23 consecutive patients with MR and no other known cardiac disease.

Results: There is a strong, linear relationship between regurgitant volume and LV end-diastolic volume index (aortic regurgitation r2 = 0.8, mitral regurgitation r2 = 0.8). Bland-Altman analysis of regurgitant volume shows little interobserver variation (AR: 0.6 +/- 4 ml; MR 4 +/- 6 ml). The correlation is much poorer between regurgitant volume and commonly used clinical linear measures such as end-systolic dimension (mitral regurgitation r2 = 0.3, aortic regurgitation r2 = 0.5). For a given regurgitant volume, AR causes greater LV enlargement and hypertrophy than MR.

Conclusion: CMR is an accurate and robust technique for quantifying regurgitant volume in patients with AR or MR. Ventricular volumes show a stronger correlation with regurgitant volume than linear dimensions, suggesting LV volumes better reflect ventricular remodeling in patients with isolated mitral or aortic regurgitation. Ventricular volumes that correspond to published recommended linear dimensions are determined to guide the timing of surgical intervention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship Between Aortic Regurgitant Volume and (A) LV EDVI, (B) LV ESVI, (C) LV EDD, and (D) LV ESD. EDD: end-diastolic dimension, EDVI: end-diastolic volume index, ESD: end-systolic dimension, ESVI: end-systolic volume index, LV: left ventricular.
Figure 2
Figure 2
Relationship Between Mitral Regurgitant Volume and (A) LV EDVI, (B) LV ESVI, (C) LV ESD, and (D) Left atrial volume. EDD: end-diastolic dimension, EDVI: end-diastolic volume index, ESVI: end-systolic volume index, LV: left ventricular.
Figure 3
Figure 3
Bland-Altman analysis of the Interobsever Agreement for the Measure of (A) Aortic and (B) Mitral Regugitant Volume. AR: aortic regurgitation, MR: mitral regurgitation.
Figure 4
Figure 4
Relationship Between of Aortic and Mitral Regurgitant Volume and LV EDVI. EDVI: end-diastolic volume index, LV: left ventricular.
Figure 5
Figure 5
Comparison of mean LV mass index according the type of regurgitant lesion and the severity of the regurgitant lesion. AR: aortic regurgitation, LVMI: left ventricular mass index, MR: mitral regurgitation.

Comment in

References

    1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1–142. doi: 10.1016/j.jacc.2008.05.007. - DOI - PubMed
    1. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, Schemper M, Maurer G, Baumgartner H. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113(18):2238–2244. doi: 10.1161/CIRCULATIONAHA.105.599175. - DOI - PubMed
    1. Wittlinger T, Dzemali O, Bakhtiary F, Moritz A, Kleine P. Hemodynamic evaluation of aortic regurgitation by magnetic resonance imaging. Asian Cardiovasc Thorac Ann. 2008;16(4):278–283. - PubMed
    1. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology. 1992;185(1):235–240. - PubMed
    1. Hundley WG, Li HF, Willard JE, Landau C, Lange RA, Meshack BM, Hillis LD, Peshock RM. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation. 1995;92(5):1151–1158. - PubMed